Skip to main content
. 2022 Sep 21;11(19):e024492. doi: 10.1161/JAHA.121.024492

Table 2.

Procedural Considerations

Ellis I/II Ellis III/IIIB P value
(n=104) (n=57)
Indication, %
Stable 51 (49.0) 24 (42.1) 0.61
Acute coronary syndrome 35 (33.7) 20 (35.1)
ST‐segment–elevation myocardial infarction 18 (17.3) 13 (22.8)
Arterial access, %
Femoral 20 (19.2) 10 (17.5) 0.002
Radial 82 (78.8) 38 (66.7)
Other 1 (1.0) 0 (0.0)
Radial and femoral 1 (1.0) 9 (15.8)
Extent coronary artery disease, %
Single VD 22 (21.2) 8 (14.0) 0.24
Two VD 36 (34.6) 16 (28.1)
Three VD 46 (44.2) 33 (57.9)
Intra‐aortic balloon pump, % 3 (2.9) 4 (7.0) 0.22
Temporary pacing line, % 1 (1.0) 2 (3.5) 0.25
Intravascular ultrasound, % 11 (10.6) 12 (21.1) 0.069
Rotablation, % 6 (5.8) 16 (28.1) <0.001
Perforated vessel, %
Left main stem 1 (1.0) 2 (3.5) 0.15
Left anterior descending 40 (38.5) 32 (56.1)
Circumflex 17 (16.3) 6 (10.5)
Right coronary artery 35 (33.7) 10 (17.5)
Graft 4 (3.8) 3 (5.3)
Diagonal 1 (1.0) 0 (0.0)
Obtuse marginal 2 (1.9) 3 (5.3)
Septal 4 (3.8) 1 (1.8)
Etiology, %
Predilatation 11 (10.6%) 5 (8.8%) <0.001
Stent 13 (12.5%) 16 (28.1%)
Post‐dilatation 23 (22.1%) 21 (36.8%)
Rotablation 1 (1.0%) 7 (12.3%)
Wire 55 (52.9%) 7 (12.3%)
Other 1 (1.0%) 1 (1.8%)
Chronic total occlusion, % 20 (19.2) 11 (19.3) 0.99
Significant calcification, % 54 (51.9) 38 (66.7) 0.071

VD indicates vessel disease.